2001 NOV 12 - (NewsRx.com & NewsRx.net) -- Diversys Ltd., a protein engineering company, has hired business development executive Pamela Hay as chief commercial officer.
is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering, and is a prolific negotiator of deals in this sector, according to the company.
has more than 15 years of legal and business development experience with major biotechnology and pharmaceutical companies.
With a degree in biology from Cornell and a law degree from the University of Wisconsin.
She joined Dyax Corp. in 1996, where she rose to become senior vice president of corporate development and strategic opportunities.
, Ms. Hay
team negotiated over 75 collaboration, technology transfer and license agreements involving the company's phage display technology and product leads, managed the company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies.
Ms. Hay will assume responsibility for the commercialization of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use.
In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio.
will be based in Diversys'
new commercial office in Cambridge, Massachusetts.
This article was prepared by Health & Medicine Week editors from staff and other reports.